Publications by authors named "Clemens Aigner"

Claim this Profile
R
RAS in lung transplantation - renin-angiotensin system and mitochondrial protection with angiotensin-1-7 during pulmonary preservation at 10 °C.
Ilker Iskender, Clemens Aigner

J Heart Lung Transplant· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term outcomes of preoperative nivolumab with or without relatlimab in patients with resectable non-small-cell lung cancer (NEOpredict-Lung).
Kristof Cuppens, Marcel Wiesweg, Paul Baas, Brigitte Maes, Bert Du Pont, Clemens Aigner

Eur J Cancer· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fibroblast growth factor signals drive the metastatic behavior in small cell lung cancer.
Büsra Ernhofer, Anna Solta, Julia Sinner, Zsolt Megyesfalvi, Abigail J Deloria, Clemens Aigner

Br J Cancer· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Small Cell Lung Cancer Classification: Unraveling Heterogeneity to Enable Personalized Treatments.
Kristiina Boettiger, Ildikó Kovács, Lilla Horvath, Büsra Ernhofer, Karin Schelch, Clemens Aigner

Cancer Res· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of YB-1 phosphorylation enhances cisplatin activity and disrupts cell division in pleural mesothelioma.
Karin Schelch, Nadine Maach, Muhammad Hashim, Benjamin Zitta, Dominik Kirchhofer, Clemens Aigner

Br J Cancer· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD38-targeted therapy with Daratumumab in clinical lung transplantation: A single-center experience.
Caroline Hillebrand, Giuseppe Maggioni, Sophia Auner, Panja Maria Boehm, Daniela Koren, Clemens Aigner

JHLT Open· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pathologic Complete Response Predicts Long-Term Survival Following Neoadjuvant Induction Chemotherapy and Chemo-Radiotherapy in Stage-III Non-Small Cell Lung Cancer.
Maja Guberina, Martin Metzenmacher, Christoph Pöttgen, Marcel Wiesweg, Nika Guberina, Clemens Aigner

Thorac Cancer· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Small cell lung cancer transdifferentiation: not a negligible phenomenon.
Lilla Horvath, Kristiina Boettiger, Zsolt Megyesfalvi, Balázs Döme, Clemens Aigner

Curr Opin Oncol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The prognostic potential of circulating biomarkers for sarcoma patients with pleural dissemination.
Hannah Schwab, Stéphane Collaud, Sebastian Bauer, Uta Dirksen, Dirk Theegarten, Clemens Aigner

Pathol Oncol Res· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Surgical Results after Neoadjuvant Nivolumab and Platinum-based Chemotherapy for Resectable Lung Cancer. A Multicentre European Real Clinical Practice Analysis.
Alessandro Brunelli, Alessio Mariolo, Clemens Aigner, David Gomez De Antonio, Marcelo Jimenez

Eur J Cardiothorac Surg· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Small Particles, Big Problems: Polystyrene nanoparticles induce DNA damage, oxidative stress, migration, and mitogenic pathways predominantly in non-malignant lung cells.
Büsra Ernhofer, Andreas Spittler, Franziska Ferk, Miroslav Mišík, Martha Magdalena Zylka, Clemens Aigner

J Hazard Mater· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serum proteomics analysis of lung transplant patients receiving different induction therapies.
Shahrooz Nasrollahi-Shirazi, Markus Unterwurzacher, Hatice Oya Berezhinskiy, Sophia Alemanno, Konrad Hoetzenecker, Clemens Aigner

Front Immunol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Contingency of Reported sST2 Serum Concentrations with a Protein Detection System (ELISA) from the Same Manufacturer (R&D Biotechne, 2002-2025): An Explanatory Effort by Applied Medical Researchers.
Marie-Therese Lingitz, Hannes Kühtreiber, Lisa Auer, Michael Mildner, Bernhard Moser, Clemens Aigner

Diagnostics (Basel)· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
LTI-03 peptide demonstrates anti-fibrotic activity in lung slices from patients with IPF.
BreAnne MacKenzie, Poornima Mahavadi, Yago Amigo Pinho Jannini-Sa, Brecht Creyns, Ana Lucia Coelho, Clemens Aigner

iScience· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
ETOP 25-23 ADOPT-lung: An international, multicentre, open-label randomised phase III trial to evaluate the benefit of adding adjuvant durvalumab after neoadjuvant chemotherapy plus durvalumab in patients with stage IIB-IIIB (N2) resectable NSCLC.
Sabine Schmid, Georgia Dimopoulou, Paul van Schil, David König, Laetitia Mauti, Clemens Aigner

Lung Cancer· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Spatial imaging features derived from SUVmax location in resectable NSCLC are associated with tumor aggressiveness.
Zewen Jiang, Clemens Spielvogel, David Haberl, Josef Yu, Maximilian Krisch, Clemens Aigner

Eur J Nucl Med Mol Imaging· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Short and long-term outcomes of children and adolescents hospitalized with COVID-19 or influenza: results of the AUTCOV study.
Christine Wagenlechner, Ralph Wendt, Berthold Reichardt, Michael Mildner, Julia Mascherbauer, Clemens Aigner

Sci Rep· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management and Outcomes of Pulmonary Nodules in a Real-World Setting.
Berta Mosleh, Pavla Sarova, Helmut Prosch, Joachim Widder, Clemens Aigner

Diagnostics (Basel)· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Using F-FDG PET/CT-derived body composition features to predict lymphovascular invasion in non-small cell lung cancer.
Zewen Jiang, David Haberl, Clemens Spielvogel, Szabolcs Szakall, Peter Molnar, Clemens Aigner

Eur J Nucl Med Mol Imaging· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circulating Antimicrobial Peptides as Biomarkers of Inflammation and Airway Dysfunction After Marathon Running.
Marie-Therese Lingitz, Hannes Kühtreiber, Lisa Auer, Michael Mildner, Claus G Krenn, Clemens Aigner

Biology (Basel)· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term outcome and prognostic factors after chest wall resection and reconstruction.
Alba M Fernandez Gonzalez, Jose R Matilla, Orsolya Anna Pipek, Laura Gonzalez Sanchez, Merjem Begic, Clemens Aigner

Interdiscip Cardiovasc Thorac Surg· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Not Available].
Clemens Aigner

Zentralbl Chir· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Health-Related Quality of Life After Pediatric Lung Transplantation.
Nicole Martin, Edith Nachbaur, Zsolt Szépfalusi, Dóra Krikovsky, Lajos Kovács, Clemens Aigner

Pediatr Pulmonol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Baseline medication load and long-term outcomes in COVID-19-hospitalized patients: results of the AUTCOVSTUDY.
Alexandra Graf, Berthold Reichardt, Christine Wagenlechner, Pavla Krotka, Denise Traxler-Weidenauer, Clemens Aigner

Front Public Health· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of KRAS mutation subtypes on morphological heterogeneity and immune landscape in surgically treated lung adenocarcinoma.
Klara Torok, Bence Ferencz, Kristiina Boettiger, Maria Dorothea Pozonec, Orsolya Pipek, Clemens Aigner

Transl Lung Cancer Res· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis